In patients with HER2-altered NSCLC and brain metastases, local therapies such as stereotactic radiosurgery (SRS), whole-brain radiotherapy (WBRT), and neurosurgical resection play crucial roles in conjunction with systemic treatments. Here, ERBB2 is linked to non-small cell lung carcinoma.